Devicor Medical Products — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

Devicor Medical Products, founded in 2009 and headquartered in Cincinnati, Ohio, is a key player in the breast care diagnostics market. The company's core business revolves around its Mammotome brand of vacuum-assisted breast biopsy (VABB) systems and associated tissue markers, which are considered the standard of care for minimally invasive breast lesion diagnosis. As a private company, it competes in a concentrated market dominated by a few large medtech players, leveraging its specialized focus and direct sales model. Its strategic position is tied to the high global incidence of breast cancer and the clinical shift towards less invasive diagnostic procedures.

Oncology

Technology Platform

Vacuum-assisted breast biopsy (VABB) systems and integrated tissue marker placement technologies for minimally invasive diagnosis and localization of breast lesions.

Opportunities

Growth is driven by the high and sustained global incidence of breast cancer and the clinical preference for minimally invasive diagnostic procedures.

Expansion into emerging markets with lower penetration of vacuum-assisted biopsy technology represents a significant untapped opportunity.

The development of higher-margin, specialized tissue markers and complementary digital tools offers avenues for increased revenue per procedure.

Risk Factors

The company operates in a highly concentrated market competing against larger, diversified medtech giants with greater resources.

It faces ongoing pricing pressure from healthcare cost containment and tender processes globally.

Long-term risk exists from potential technological disruption, such as advanced imaging or liquid biopsies reducing the need for tissue sampling.

Competitive Landscape

Devicor competes in the breast biopsy device market against major players like Hologic (ATEC system), Becton Dickinson (BD), and Argon Medical Devices. The market is characterized by intense competition on product features, clinical data, price, and service. Devicor's Mammotome brand holds strong historical recognition but must continuously innovate to defend its market share against well-funded rivals with integrated breast health ecosystems.

More companies in Diagnostics & Precision Medicine →More companies in United States →